An Open-label, Dose Escalation Trial to Evaluate the Safety and Pharmacokinetics of HMPL-523 in Patients With Lymphoma

NCT03779113 · clinicaltrials.gov ↗
PHASE1
Phase
TERMINATED
Status
69
Enrollment
INDUSTRY
Sponsor class

Stopped Study terminated by sponsor

Conditions

Interventions

Sponsor

Hutchmed